Russian Health Ministry Rejects Ovoca Bio's BP-101 Application
Russian Health Ministry Rejects Ovoca Bio's BP-101 Application
Read moreFri, 02nd Oct 2020 10:10
Russian Health Ministry Rejects Ovoca Bio's BP-101 Application
Read moreUK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief
Read moreIN BRIEF: Ovoca Bio Pretax Loss Widens In First Half Of 2020
Read moreOvoca Bio Annual Loss Slightly Narrows; Capital Base "Strong"
Read moreOvoca Bio Completes Buyout Of Russia's IVIX For USD5 Million
Read more(Sharecast News) - Biopharmaceutical firm Ovoca Bio narrowed losses slightly in the first half of its trading year, while focus remained firmly on its continued development of a treatment for female sexual dysfunction.
Read more(Alliance News) - Ovoca Bio PLC on Monday said its loss widened in the first half of the year, suffering higher administration expenses in the year as it worked to develop its BP-101 female sexual
Read more(Alliance News) - Ovoca Bio PLC on Wednesday said Non-Executive Director Nikolay Myasoyedov intends to step down from the board with immediate effect for personal reasons.The pharmaceutical
Read more(Alliance News) - Ovoca Bio PLC on Thursday said it intends to file for the approval of its Libicore female sexual dysfunction drug later in the quarter and expects the verdict in a year's 16%
Read more(Alliance News) - Drug company Ovoca Bio PLC said on Friday Yuri Radchenko, a non-executive director, has stepped down with immediate effect due to personal reasons.Chief Executive Kirill I
Read more(Alliance News) - Ovoca Bio PLC on Friday said its annual loss widened heavily as a result of administration expenses and said it is preparing to file for marketing approval of its drug BP101 in a
Read more(Sharecast News) - Ovoca Bio announced on Tuesday that its subsidiary IVIX has begun the process of preparing an integrated clinical development plan for its investigational drug candidate, 'Libicore' (BP-101), for both the US and EU regions with US-based contract research organisation Biorasi.
Read moreLONDON (Alliance News) - Ovoca Bio PLC said Wednesday it increased its stake in a majority-owned subsidiary following a positive set of test results from its Libicore sexual desire - known as Gold
Read moreLONDON (Alliance News) - Ovoca Bio PLC on Monday said it intends to file for the approval of its hypoactive sexual desire disorder drug Libicore in Russia after positive results from a recent in a
Read more